Web Results

Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc.


Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc. 1:15-cv-00114; Filed: 01/30/2015; Case Updated Daily; Latest Docket Entry: 06/13/2016; PACER.

United States ex rel. Gohil v. Sanofi-Aventis U.S. Inc.


Mar 30, 2015 ... ex rel. YOASH GOHIL,. Plaintiff, v. SANOFI-AVENTIS U.S. INC., et. al. Defendant. ... which caused numerous healthcare providers to submit false claims to federally funded ... the marketing, promotion and sale of pharmaceuticals manufactured by Aventis. ..... See Atkinson, 473 F.3d at 513 (approving of.

Patent Docs: Bayer Healthcare Pharmaceuticals, Inc. v. Watson ...


Apr 24, 2013 ... Watson Pharmaceuticals, Inc. But, unfortunately, it's a rather ... Briefs in Support of Sequenom's Petition for Certiorari: Eli Lilly and Company et al. ... Federal Circuit's recent decision in Bayer Healthcare Pharmaceuticals, Inc. v.

460 F.3d - Volume 460 of the Federal Reporter, 3rd Series :: U.S. ...


The Fund for Animals, Inc., et al., Appellants v. .... Eve Atkinson, Appellant v. ... Baldwin, F/k/a C-p Pharmaceuticals, Inc.; Diamond Shamrock Chemicals Company, ..... Ncs Healthcare of Illinois, Inc. & Ncs Healthcare, Inc., Defendants- appellees .... Bayer Corporation, et al., Defendants-appellees.leon Anderson, Jr., et al.,* ...

Judge Nathaniel M. Gorton - PlainSite


... v. Experian Information Solutions, Inc. et al ... v. Dental Resource Systems, Inc. et al ... v. Bayer Healthcare Pharmaceuticals, Inc. .... Par Pharmaceutical, Inc. et.

Intellectual Property Proceedings in Federal Court for 2012 | IPPractice


File No. Style of Cause, Proceeding Type, Date Started, Firms*

Equal Pay: Proving or Disproving the Existence of Unlawful Pay Bias


Mar 22, 2012 ... Wal-Mart Stores, Inc. v. Dukes, 564 U.S. __, ... Barghout, et al. v. Bayer Healthcare Pharmaceuticals, et al., No. ..... Harris v. Auxilium Pharms., Inc., 664 F. Supp. 2d 711 (S.D. Tex. 2009). ..........44 ..... Atkinson v. Washington Int'l ...

Survivorship: Fatigue, Version 1.2014


A meta-analysis by Duijts et al reported that, like exercise programs, .... Crystal S. Denlinger, MD, Bayer HealthCare; ImClone Systems Incorporated; MedImmune Inc.; ... Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Pfizer Inc. None ... Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and  ...

Comparison of Outcomes after Transplantation of G-CSF Stimulated ...


Oct 27, 2010 ... The diagnostic criteria of SAA are similar to those of Camitta et al., modified so that a ... 6 months), number of red blood cell transfusions prior to transplantation ( ≤ 20 vs. > .... Astellas Pharma US, Inc.; Baxter International, Inc.; Bayer HealthCare Pharmaceuticals; .... Atkinson K, Horowitz MM, Gale RP, et al.

Patient-reported treatment satisfaction and budget impact with ...


Oct 20, 2015 ... To estimate the budget impact of rivaroxaban vs. .... Lane et al. have recently published a consensus statement on patients' values and ... This study was supported by Bayer HealthCare Pharmaceuticals and Janssen ... Merck, Johnson & Johnson, Gilead, Janssen Scientific Affairs, Pozen, Inc., and Coherex.

More Info

New York Southern District Court Information Page - PacerMonitor


Edelman Arts, Inc. et al v. Star Net Insurance .... The Containership Company ( TCC) A/S et al v. Apex Maritime Co. ... Nature of suit: Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability ..... Atkinson v. ...... Bayer HealthCare Pharmaceuticals Inc. et al Court: New York Southern District Court

Pattishall, McAuliffe has Successfully Handled many Trials, Appeals ...


2016, Bayer Consumer Care AG et al. v. ... 2015, Meda Consumer Healthcare, Inc. v. ... 2015, Robert Bosch GmbH and Robert Bosch LLC v. ..... Judson- Atkinson Candies, Inc., Opposition Nos. ..... BioRx Pharmaceuticals, Inc., Opposition No.

2013 Southern District of New York U.S. Federal District Court Case ...


Sax v. New Oriental Education & Technology Group, Inc. et al ..... Commission v. One Or More Unknown Traders In The Securities Of Onyx Pharmaceuticals, Inc.